AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,540,726 | -2.7% | 93,586 | 0.0% | 1.75% | +29.0% |
| Q2 2023 | $6,725,090 | +54.9% | 93,586 | +32.9% | 1.35% | +20.0% |
| Q1 2023 | $4,342,395 | +8.3% | 70,402 | +35.5% | 1.13% | +8.5% |
| Q4 2022 | $4,008,832 | -3.0% | 51,975 | -47.9% | 1.04% | -6.2% |
| Q1 2022 | $4,132,000 | +5.8% | 99,834 | -3.5% | 1.11% | +55.8% |
| Q4 2021 | $3,907,000 | +7.6% | 103,405 | -6.1% | 0.71% | +26.5% |
| Q3 2021 | $3,631,000 | – | 110,155 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |